Act on Covid-19 Vaccine Intellectual Property Rights - SADC

Members of the Southern African Development Community's (SADC) Parliament have called for action on Covid-19 vaccine intellectual property rights by building the region's capacity to produce medicines and to ensure that citizens benefit from the region's vast medicinal plant resources. The main challenge with intellectual property rights and access to medicines in sub-Saharan Africa is the gap between the huge disease burden and the slow uptake of Trade-Related Aspects of Intellectual Property Rights (Trips) flexibilities that are freely available to the countries because of "structural and technical factors," said Nyasha Chingore, programmes lead at the AIDS and Rights Alliance for Southern Africa. While the U.S., UK and Canada have actively blocked a patent-waiver proposal intended to increase the global production of Covid-19 vaccines, White House officials stated that the U.S. may reverse its position, though no decision has yet been made.

As of April 29, 2021, the continent hass recorded 4,532,203 cases of Covid-19 of which 121,141 proved fatal and 4,073,969. The number of vaccinations to date total 12,216,007.

InFocus

(file photo).

Don't Miss

AllAfrica publishes around 900 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.